Cite

HARVARD Citation

    Fabbri, M. et al. (n.d.). 207PEfficacy and safety of neoadjuvant chemotherapy plus trastuzumab and pertuzumab in non-metastatic HER2-positive breast cancer in real life: NEOPEARL study. Annals of oncology. p. . [Online]. 
  
Back to record